GENERAL INFORMATION AND OTHER FINANCIAL DATA - EARNINGS PER COMMON SHARE (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Earnings attributable to common shares		$ 559	$ 424	$ 1,171	$ 1,298
Earnings attributable to common shares		$ 559	$ 424	$ 1,171	$ 1,298
Weighted-average common shares outstanding for basic EPS (in shares)		314,845,000	307,800,000	315,595,000	304,372,000
Dilutive effect of stock options and RSUs (in shares)		1,022,000	807,000	1,052,000	846,000
Dilutive effect of mandatory convertible preferred stock (in shares)		0	0	0	1,066,000
Weighted-average common shares outstanding for diluted EPS (in shares)		315,867,000	308,607,000	316,647,000	306,284,000
Earnings per share, basic (dollars per share)		$ 1.78	$ 1.38	$ 3.71	$ 4.27
Earnings per share, diluted (in dollars per share)		$ 1.77	$ 1.37	$ 3.70	$ 4.24
Vested RSUs included in basic WASO (in shares)		399,000	447,000	403,000	454,000
Stock options, RSAs and RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Non-qualified stock options granted (in shares)	219,898
Performance-based RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Equity awards, granted (in shares)	338,080
Service-based RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Equity awards, granted (in shares)	150,286
Stock options, RSAs and RSUs
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Antidilutive securities excluded from earnings per share (in shares)		8,899	145,247	173,064	287,061
Convertible Preferred Stock
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Antidilutive securities excluded from earnings per share (in shares)			4,256,725		4,256,725